Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Insight Molecular Diagnostics Inc. Director's Dealing 2024

Jun 24, 2024

34238_dirs_2024-06-24_0776c028-abc1-421e-b69a-f40d3a9eac74.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Oncocyte Corp (OCX)
CIK: 0001642380
Period of Report: 2024-06-17

Reporting Person: James Andrea S. (Chief Financial Officer)

More from Insight Molecular Diagnostics Inc.

Annual Report 2026
Apr 30
Regulatory Filings 2026
Apr 30
Regulatory Filings 2026
Feb 26
Director's Dealing 2026
Feb 12
Major Shareholding Notification 2026
Feb 12
Regulatory Filings 2026
Feb 12
Regulatory Filings 2026
Feb 11
Regulatory Filings 2026
Feb 11
Director's Dealing 2025
Nov 13
Interim / Quarterly Report 2025
Nov 10
View all filings →